Antitumor activity of the selective ALK inhibitor alectinib in models of intracranial metastases

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, September 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

So far, Altmetric has seen 1 X post from an account with 286 followers.

Antitumor activity of the selective ALK inhibitor alectinib in models of intracranial metastases. - PubMed - NCBI https://t.co/KMnhc53I6P